GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of cytokine production | ||
secretory granule localization | ||
phosphatidylinositol 3-kinase/protein kinase B signal transduction | ||
phosphatidylinositol phosphate biosynthetic process | ||
endocytosis |
GO Term | Evidence Code | PMID |
---|---|---|
1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | ||
kinase activity | ||
protein binding | ||
protein serine kinase activity | ||
1-phosphatidylinositol-4-phosphate 3-kinase activity |
Gene Ontology |
---|
1-phosphatidylinositol-4-phosphate 3-kinase activity |
kinase activity |
phosphatidylinositol-mediated signaling |
phosphorylation |
transferase activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050211 | swine influenza | |
DOID:12849 | autistic disorder | |
DOID:3498 | pancreatic ductal adenocarcinoma | |
DOID:5082 | liver cirrhosis | |
DOID:612 | primary immunodeficiency disease | |
DOID:8947 | diabetic retinopathy |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000010 | Recurrent urinary tract infections |
HP:0000403 | Recurrent otitis media |
HP:0000964 | Eczematoid dermatitis |
HP:0001252 | Hypotonia |
HP:0001433 | Hepatosplenomegaly |
HP:0001581 | Recurrent skin infections |
HP:0001742 | Nasal congestion |
HP:0001744 | Splenomegaly |
HP:0001873 | Thrombocytopenia |
Disease ID | Disease Name |
---|---|
OMIM:619802 |
|
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
103732179 | NANGA02072 | |||
103813517 | SERCA06309 | |||
104677402 | RHIRO25811 | |||
105300332 | PTEVA03950 | |||
105475319 | MACNE00055 | |||
105544111 | MANLE13547 | |||
105583147 | CERAT13725 | |||
105720275 | AOTNA21031 | |||
105815179 | PROCO05914 | |||
106576084 | SALSA52429 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024